Your browser doesn't support javascript.
loading
Development and deployment of COVID-19 vaccines for those most vulnerable.
Koff, Wayne C; Schenkelberg, Theodore; Williams, Tere; Baric, Ralph S; McDermott, Adrian; Cameron, Cheryl M; Cameron, Mark J; Friemann, Matthew B; Neumann, Gabriele; Kawaoka, Yoshihiro; Kelvin, Alyson A; Ross, Ted M; Schultz-Cherry, Stacey; Mastro, Timothy D; Priddy, Frances H; Moore, Kristine A; Ostrowsky, Julia T; Osterholm, Michael T; Goudsmit, Jaap.
Afiliação
  • Koff WC; Human Vaccines Project, New York, NY 10119, USA. wkoff@humanvaccinesproject.org.
  • Schenkelberg T; Human Immunomics Initiative, Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA 02115, USA.
  • Williams T; Human Vaccines Project, New York, NY 10119, USA.
  • Baric RS; Human Immunomics Initiative, Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA 02115, USA.
  • McDermott A; Department of Pathology, Albert Einstein College of Medicine Bronx, NY 10461, USA.
  • Cameron CM; Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27599, USA.
  • Cameron MJ; Vaccine Immunology Program, Vaccine Research Center, National Institutes of Health, Bethesda, MD 20814, USA.
  • Friemann MB; School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.
  • Neumann G; School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.
  • Kawaoka Y; Department of Microbiology and Immunology, University of Maryland at Baltimore, Baltimore, MD School of Medicine, Baltimore, MD 21201, USA.
  • Kelvin AA; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI 53706, USA.
  • Ross TM; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI 53706, USA.
  • Schultz-Cherry S; Institute of Medical Science, University of Tokyo, Bunkyo City, Tokyo 113-8654, Japan.
  • Mastro TD; Departments of Pediatrics, Microbiology and Immunology, Dalhousie University, Halifax, NS B3H 4R2, Canada.
  • Priddy FH; Animal Health Research Center, Center for Vaccines, Immunology and Infectious Disease, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA.
  • Moore KA; Infectious Diseases Research, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • Ostrowsky JT; FHI 360, Durham, NC 27701, USA.
  • Osterholm MT; Vaccine Alliance Aotearoa New Zealand, Malaghan Institute of Medical Research, Wellington 6242, New Zealand.
  • Goudsmit J; Center for Infectious Disease Research and Policy (CIDRAP), University of Minnesota, Minneapolis MN 55455, USA.
Sci Transl Med ; 13(579)2021 02 03.
Article em En | MEDLINE | ID: mdl-33536277
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Suscetibilidade a Doenças / Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Sci Transl Med Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Suscetibilidade a Doenças / Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Sci Transl Med Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos